These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22527345)

  • 61. [Centrally acting muscle relaxants and traffic hazards].
    Bramness JG; Skurtveit S; Grung M; Mørland J
    Tidsskr Nor Laegeforen; 2000 Jun; 120(17):1966-9. PubMed ID: 11008526
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Genetic polymorphisms and novel allelic variants of CYP2C19 in the Chinese Han population.
    Hu LM; Dai DP; Hu GX; Yang JF; Xu RA; Yang LP; Qian JC; Ge RS; Cai JP
    Pharmacogenomics; 2012 Nov; 13(14):1571-81. PubMed ID: 23148634
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Allele and genotype frequency of CYP2C19 in a Tamilian population.
    Adithan C; Gerard N; Vasu S; Rosemary J; Shashindran CH; Krishnamoorthy R
    Br J Clin Pharmacol; 2003 Sep; 56(3):331-3. PubMed ID: 12919183
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Association between genetic polymorphisms of CYP2C19 and CYP2C9 and phenytoin serum concentration].
    Huang Y; Yang JF; Qi XL; Wang YQ; Wang WZ; Chen B
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1686-9. PubMed ID: 15569425
    [TBL] [Abstract][Full Text] [Related]  

  • 65. CYP2C19*2 and CYP2C19*3 allelomorphism in Turkish population.
    Dogan A
    Int J Cardiol; 2017 Jul; 239():12. PubMed ID: 28560959
    [No Abstract]   [Full Text] [Related]  

  • 66. Prevalence of CYP2C19 variant alleles and pharmacodynamic variability of aspirin and clopidogrel in Native Americans.
    Oestreich JH; Best LG; Dobesh PP
    Am Heart J; 2014 Mar; 167(3):413-8. PubMed ID: 24576527
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Establishment of a CYP2C19 genotyping assay for clinical use.
    Cervinski MA; Schwab MC; Lefferts JA; Lewis LD; Lebel KA; Tyropolis AM; Pflueger SM; Tsongalis GJ
    Am J Clin Pathol; 2013 Feb; 139(2):202-7. PubMed ID: 23355205
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Carisoprodol use and abuse in Norway: a pharmacoepidemiological study.
    Bramness JG; Furu K; Engeland A; Skurtveit S
    Br J Clin Pharmacol; 2007 Aug; 64(2):210-8. PubMed ID: 17298482
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prevalence of CYP2C19 polymorphisms in the Lebanese population.
    Djaffar Jureidini I; Chamseddine N; Keleshian S; Naoufal R; Zahed L; Hakime N
    Mol Biol Rep; 2011 Nov; 38(8):5449-52. PubMed ID: 21380557
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Novel mutations in the cytochrome P450 2C19 gene: a pitfall of the PCR-RFLP method for identifying a common mutation.
    Ohkubo Y; Ueta A; Ando N; Ito T; Yamaguchi S; Mizuno K; Sumi S; Maeda T; Yamazaki D; Kurono Y; Fujimoto S; Togari H
    J Hum Genet; 2006; 51(2):118-123. PubMed ID: 16307177
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.
    Jose R; Chandrasekaran A; Sam SS; Gerard N; Chanolean S; Abraham BK; Satyanarayanamoorthy K; Peter A; Rajagopal K
    Fundam Clin Pharmacol; 2005 Feb; 19(1):101-5. PubMed ID: 15660966
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Is the prevalence of CYP2C19 genetic variants different in Pacific people than in New Zealand Europeans?
    Helsby N; Goldthorpe M; Gow P; de Zoysa J
    N Z Med J; 2010 May; 123(1315):37-41. PubMed ID: 20581929
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pharmacogenomics of clopidogrel: evidence and perspectives.
    Yin T; Miyata T
    Thromb Res; 2011 Oct; 128(4):307-16. PubMed ID: 21592545
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10 + 12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients.
    Giusti B; Gori AM; Marcucci R; Saracini C; Sestini I; Paniccia R; Valente S; Antoniucci D; Abbate R; Gensini GF
    Pharmacogenet Genomics; 2007 Dec; 17(12):1057-64. PubMed ID: 18004210
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Quantitative assessment of the influence of cytochrome P450 2C19 gene polymorphisms and digestive tract cancer risk.
    Yao L; Wang HC; Liu JZ; Xiong ZM
    Tumour Biol; 2013 Oct; 34(5):3083-91. PubMed ID: 23754447
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Single and Multiple Dose PK-PD Characterization for Carisoprodol. Part I: Pharmacokinetics, Metabolites, and 2C19 Phenotype Influence. Double-Blind, Placebo-Controlled Clinical Trial in Healthy Volunteers.
    Calvo A; Alonso S; Prieto E; Ascaso-Del-Rio A; Ortuño J; Fernandez N; Portolés A
    J Clin Med; 2022 Feb; 11(3):. PubMed ID: 35160309
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Abuse Potential of Soma: the GABA(A) Receptor as a Target.
    Gonzalez LA; Gatch MB; Forster MJ; Dillon GH
    Mol Cell Pharmacol; 2009 Jan; 1(4):180-186. PubMed ID: 20419052
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Toxicity of Somadril Compound on Fetal Ileum Tissues of Albino Rats.
    Ahmed Abd Rabou M; Alhumaidi Alotaibi M
    Pak J Biol Sci; 2021 Jan; 24(1):72-79. PubMed ID: 33683033
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A case report of carisoprodol dependence.
    Venugopal D; Deepak G; Murali N; Kumar KB; Sharma PS
    Indian J Psychiatry; 2000 Apr; 42(2):211-3. PubMed ID: 21407939
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Carisoprodol Single and Multiple Dose PK-PD. Part II: Pharmacodynamics Evaluation Method for Central Muscle Relaxants. Double-Blind Placebo-Controlled Clinical Trial in Healthy Volunteers.
    Calvo A; González-Hidalgo M; Terleira A; Fernández N; Portolés A
    J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.